Konstantinos Xynos, Chief Medical Officer at Replimune Group, Inc. (REPL), sold 14,626 shares at $10.92 ($160K) on 2023-11-16, disclosed to the SEC on 2023-11-17.
Open-market sale of $160k REPL by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.92 | 7,313 | $80K | 50.0% |
| 2 | $10.92 | 7,313 | $80K | 50.0% |
| Total | $10.92 avg | 14,626 | $160K | 100% |
| Filing → |
| REPL | SELL | 2025-11-19 | $132K | — | Filing → |
| REPL | SELL | 2025-05-22 | $128K | — | Filing → |
| REPL | SELL | 2024-11-20 | $156K | — | Filing → |